Sirona Biochem

103 articles about Sirona Biochem

• Sirona Biochem Presents: SmallCap-Investor Interview With Attila Hajdu

  2/16/2016

• Sirona Biochem Invited To Present At Dose Of The Valley Conference, San Francisco

  1/25/2016

• Sirona Biochem Retains Strategic Advisor To Commercialize Glycoproteins

  11/3/2015

• Sirona Biochem Presents New Results From Glycoprotein Program At BIO-Europe

  10/26/2015

• Sirona Biochem Reaches Major Milestone By Successful Scale-Up Of Skin Lightening Compound SBM-TFC-1067

  9/15/2015

• Sirona Biochem Appoints German Private Bank Hauck & Aufhauser As Designated Sponsor For Xetra

  9/14/2015

• Sirona Biochem Announces Results Of Shareholder Meeting

  8/26/2015

• Sirona Biochem Appoints Casper Bych To Its Board of Directors

  6/29/2015

• Sirona Biochem CEO Update: Significant Interest From Top Cosmetic And Pharmaceutical Companies For Lead Compounds

  6/3/2015

• Sirona Biochem To Present At Industry’s Premier Conference - BIO International Convention 2015

  5/4/2015

• Sirona Biochem To Present At BioNetwork East - May 2015

  4/13/2015

• Sirona Biochem Announces Positive Results With SBM-TFC-837 for Anti-Aging And Regenerative Medicine

  3/24/2015

• Sirona Biochem To Present At BIO Asia And Received Over $1.1 Million Of Warrants Exercised

  3/13/2015

• Sirona Biochem Announces Successful Development Of A Third Skin Lightener With Superior Safety And Efficacy

  3/11/2015

• Sirona Biochem: Positive Preclinical Toxicology Results For Its SGLT2 Inhibitor Trigger Milestone Payment From Wanbang Biopharmaceuticals

  3/4/2015

• Sirona Biochem Appoints Dr. Martin Gleave To Its Board Of Directors

  2/25/2015

• Sirona Biochem To Present New Results At BIO Europe 2015

  2/18/2015

• Sirona Biochem Invited To Present At Dose Of The Valley Conference, San Francisco

  1/26/2015

• Sirona Biochem's Subsidiary, TFChem, Awarded Prestigious French Innovation Trophy

  12/2/2014

• Sirona Biochem Names Attila Hajdu As Chief Business Development Officer

  10/27/2014